| 11590128 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor |
Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more |
2023-02-28 |
| 11413282 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor |
Christian Klein, Wayne Fairbrother |
2022-08-16 |
| 11110087 |
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor |
Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more |
2021-09-07 |
| 10993942 |
Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor |
Christian Klein, Wayne Fairbrother, Sari L. Heitner Enschede, Rod A. Humerickhouse, Andrew W. Roberts +1 more |
2021-05-04 |
| 10959993 |
Combination of Bcl-2 inhibitor and MEK inhibitor for the treatment of cancer |
Mark Merchant, Marina Konopleva, Lina Han |
2021-03-30 |
| 10898570 |
Combination therapy with an anti-HER2 antibody-drug conjugate and a Bcl-2 inhibitor |
Gail Lewis Phillips, Ingrid Wertz |
2021-01-26 |
| 10092567 |
Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use |
Kui Lin, Michelle Nannini, Elizabeth Punnoose, Jeffrey Wallin, Premal Patel |
2018-10-09 |
| 9855270 |
Methods and compositions for modulating estrogen receptor mutants |
Jeffrey J. Hager, James D. Joseph, Jing Qian, Nicholas D. Smith, Edna Chow Maneval +2 more |
2018-01-02 |
| 9717730 |
Combinations of AKT inhibitor compounds and chemotherapeutic agents, and methods of use |
Kui Lin, Michelle Nannini, Elizabeth Punnoose, Jeffrey Wallin, Premal Patel |
2017-08-01 |
| 9682082 |
Combinations of AKT and MEK inhibitor compounds, and methods of use |
Brian Lee, Kui Lin, Michelle Nannini, Elizabeth Punnoose |
2017-06-20 |
| 9610289 |
Combinations of AKT inhibitor compounds and erlotinib, and methods of use |
Michelle Nannini |
2017-04-04 |
| 9539251 |
Combination therapy of a type II anti-CD20 antibody with a selective Bcl-2 inhibitor |
Christian Klein, Wayne Fairbrother |
2017-01-10 |
| 9346789 |
Combinations of AKT inhibitor compounds and abiraterone, and methods of use |
Michelle Nannini |
2016-05-24 |
| 9150549 |
Combinations of AKT inhibitor compounds and erlotinib, and methods of use |
Michelle Nannini |
2015-10-06 |
| 9107926 |
Mutant selectivity and combinations of a phosphoinositide 3-kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer |
Marcia Belvin, Lori Friedman, Jeffrey Wallin |
2015-08-18 |
| 8604014 |
Combinations of phosphoinositide 3-kinase inhibitor compounds chemotherapeutic agents, and methods of use |
Marcia Belvin, Lori Friedman, Klaus Hoeflich, Ulka Vijapurkar, Jeffrey Wallin +3 more |
2013-12-10 |
| 8247397 |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
Marcia Belvin, Lori Friedman, Klaus Hoeflich, Ulka Vijapurkar, Jeffrey Wallin +3 more |
2012-08-21 |
